Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee

PHASE2CompletedINTERVENTIONAL
Enrollment

169

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

October 31, 2008

Conditions
Osteoarthritis of the Knee
Interventions
DRUG

Lidoderm (Lidocaine 5% Patch)

Topical Patch

DRUG

Placebo Patch

Topical Patch

Trial Locations (20)

16635

Altoona Center for Clinical Research, Duncansville

21702

Arthritis & Osteoporosis Center of Maryland, Frederick

23454

Advanced Pain Management & Rehabilitation, Hilltop Medical, Virginia Beach

33484

Delray Research Associates, Delray Beach

33606

Clinical Research of West Florida, Tampa

33702

CNS Clinical Trials, St. Petersburg

33761

Tampa Bay Medical Research, Inc., Clearwater

44122

University Hospitals of Case Medical Center - Arthritis Translational Research Program, Beachwood

45245

Community Research, Cincinnati

57702

Health Concepts, Rapid City

63376

Midwest Pharmaceutical Research, City of Saint Peters

68516

Arthritis Center of Nebraska, Lincoln

73103

Health Research of Oklahoma, Oklahoma City

78217

Radiant Research, San Antonio

85016

NextCare Institute for Clinical Research, Phoenix

85050

HOPE Research Institute, LLC, Phoenix

85253

Arizona Arthritis Research, PLC, Paradise Valley

06460

Clinical Research Consulting, Milford

06611

New England Research Associates, LLC, Trumbull

08009

Comprehensive Clinical Research, Berlin

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY